News
Recent Posts
- Novartis pays $12B for Avidity and its muscle-targeting RNA platform
- My family caregivers are feeling the pressure
- BBP-418 improves walking ability in LGMD2i patients in Phase 3 trial
- I’m giving everything I have for Duchenne MD — in my own way
- DMD treatment Agamree may avoid issues of traditional steroids